Genetics of coagulation factors in acute lung injury

Critical Care Medicine

Volumn 31, Issue 4 SUPPL., 2003, Pages

  Russell, James A ^a  

^a ST PAUL S HOSPITAL   (Canada)

Author keywords

Endothelial protein C receptor; Factor V; Fibrin; Fibrinogen; Interleukin 1; Interleukin 6; Interleukin 8; Plasminogen activator inhibitor 1; Protein C; Single nucleotide polymorphisms; Tumor necrosis factor ; thrombin

Indexed keywords

BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 10A INHIBITOR; BLOOD CLOTTING FACTOR 5; FIBRIN; FIBRINOGEN; INTERLEUKIN 1; INTERLEUKIN 6; INTERLEUKIN 8; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN C; THROMBIN; THROMBOPLASTIN; TUMOR NECROSIS FACTOR ALPHA;

ANTICOAGULATION; ASPIRATION; BLOOD CLOTTING; CONFERENCE PAPER; DEEP VEIN THROMBOSIS; DISSEMINATED INTRAVASCULAR CLOTTING; ENDOTHELIUM; FIBRINOLYSIS; GENETIC CODE; GENETIC PREDISPOSITION; HEART INFARCTION; IN VITRO STUDY; INFLAMMATION; LUNG ALVEOLUS; LUNG EMBOLISM; LUNG INJURY; MEDLINE; MONOCYTE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROMOTER REGION; RISK FACTOR; SEPSIS; SINGLE NUCLEOTIDE POLYMORPHISM; STIMULUS; STROKE; SYSTEMIC CIRCULATION;

EID: 0037393046     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ccm.0000057870.61079.3e     Document Type: Conference Paper

References (24)

1. Holmes C, Russell JA, Walley KR: Genetics of sepsis. Chest, In Press
2. Menges T, Hermans PW, Little SG, et al: Plasminogen-activator-inhibitor-1 4G/5G promoter polymorphism and prognosis of severely injured patients. Lancet 2001; 357:1096-1097
3. Nawroth PP, Stern DM: Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med 1986; 163:740-745
4. Johnson K, Aarden L, Choi Y, et al: The proinflammatory cytokine response to coagulation and endotoxin in whole blood. Blood 1996; 87:5051-5060
5. Johnson K, Choi Y, DeGroot E, et al: Potential mechanisms for a proinflammatory vascular cytokine response to coagulation activation. J Immunol 1998; 160:5130-5135
6. Sower LE, Froelich CJ, Carney DH, et al: Thrombin induces IL-6 production in fibroblasts and epithelial cells. Evidence for the involvement of the seven-transmembrane domain (STD) receptor for alpha-thrombin. J Immunol 1995; 155:895-901
7. Bernard GR, Vincent JL, Laterre PF, et al: Recombinant human protein C: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344:699-709
8. Idell S, Gonzalez KK, MacArthur CK, et al: Bronchoalveolar lavage procoagulant activity in bleomycin-induced lung injury in marmosets. Characterization and relationship to fibrin deposition and fibrosis. Am Rev Respir Dis 1987; 136:124-133
9. Idell S, James KK, Levin EG, et al: Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome. J Clin Invest 1989; 84:695-705
10. Bertozzi P, Astedt B, Zenzius L, et al: Depressed bronchoalveolar urokinase activity in patients with adult respiratory distress syndrome. N Engl J Med 1990; 322:890-897
11. Sitrin RG, Brubaker PG, Fantone JC: Tissue fibrin deposition during acute lung injury in rabbits and its relationship to local expression of procoagulant and fibrinolytic activities. Am Rev Respir Dis 1987; 135:930-936
12. Sueishi K, Nanno S, Tanaka K: Permeability enhancing and chemotactic activities of lower molecular weight degradation products of human fibrinogen. Thromb Haemost 1981; 45:90-94
13. Ferrara JJ, Kan C, Luterman A, et al: Effects of fibrinogen degradation fragments D and E on cell-mediated immunity. J Surg Res 1989; 47:134-137
14. Senior RM, Skogen WF, Griffin GL, et al: Effects of fibrinogen derivatives upon the inflammatory response. Studies with human fibrinopeptide B. J Clin Invest 1986; 77:1014-1019
15. Seeger W, Hubel J, Klapettek K, et al: Procoagulant activity in bronchoalveolar lavage of severely traumatized patients: Relation to the development of acute respiratory distress. Thromb Res 1991; 61:53-64
16. Lane DA, Grant PJ: Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease. Blood 2000; 95:1517-1529
17. Iacoviello L, Vischetti M, Zito F, et al: Genes encoding fibrinogen and cardiovascular risk. Hypertension 2001; 38:1199-1203
18. Boekholdt SM, Bijsterveld NR, Moons AH, et al: Genetic variation in coagulation and fibrinolytic proteins and their relation with acute myocardial infarction: A systematic review. Circulation 2001; 104:3063-3068
19. Spek CA, Greengard JS, Griffin JH, et al: Two mutations in the promoter region of the human protein C gene both cause type I protein C deficiency by disruption of two HNF-3 binding sites. J Biol Chem 1995; 270:24216-24221
20. Spek CA, Koster T, Rosendaal FR, et al: Genotypic variation in the promoter region of the protein C gene is associated with plasma protein C levels and thrombotic risk. Arterioscler Thromb Vasc Biol 1995; 15:214-218
21. Aiach M, Nicaud V, Alhenc-Gelas M, et al: Complex association of protein C gene promoter polymorphism with circulating protein C levels and thrombotic risk. Arterioscler Thromb Vasc Biol 1999; 19:1573-1576
22. Spek CA, Reitsma PH: Genetic risk factors for venous thrombosis. Mol Genet Metab 2000; 71:51-61
23. Merati G, Biguzzi B, Oganesyan F, et al: A 23 bp insertion in the endothelial protein C receptor (EPCR) gene in patients with myocardial infarction and deep vein thrombosis. Thromb Haemost 1999; 82:507
24. Hermans PW, Hibberd ML, Booy R, et al: 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease. Meningococcal Research Group. Lancet 1999; 354:556-560